for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up
Healthcare

BRIEF-Innovent Biologics Enters Strategic Collaboration Agreement With University Of Texas MD Anderson Cancer Center

May 19 (Reuters) - Innovent Biologics Inc:

* INNOVENT BIOLOGICS INC- ENTERED INTO A STRATEGIC COLLABORATION AGREEMENT WITH UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER

* INNOVENT BIOLOGICS - AGREEMENT TO CO-DEVELOP TYVYT IN RARE CANCERS IN UNITED STATES

* INNOVENT BIOLOGICS INC- STUDIES WILL PROVIDE OPPORTUNITIES FOR CO TO PURSUE APPROVAL OF SINTILIMAB BY U.S. FDA FOR MULTIPLE RARE CANCER INDICATIONS Source text for Eikon: Further company coverage:

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up